icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Mon 26 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

الأخبار العلمية

4564
icon 2025-12-01

Global Leadership for Increasing Patient Accessibility, SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia (HoFH)

The Saudi Food and Drug Authority (SFDA) announced its approval of a new medical claim for Lojuxta (lomitapide), allowing its use to treat children...
More
1
icon 2026-07-02

mRNA Technology Shapes the Future of Modern Therapies: SFDA Advances Regulatory Frameworks to Foster Innovation and Protect Patient Safety

Therapies based on messenger RNA (mRNA) technology are advancing rapidly, positioning them among the world's most breakthrough medical technologies...
More
d
icon 2025-07-23

SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder

The Saudi Food and Drug Authority (SFDA) has approved the registration of Skyclarys (Omaveloxolone), which was previously designated as an Orphan Drug...
More
sg
icon 2025-08-04

SFDA Announces the Registration of Pyrukynd for the Treatment of Thalassemia

The Saudi Food and Drug Authority (SFDA) has approved the registration of Pyrukynd (Mitapivat) for the treatment of adult patients with alpha- or beta...
More
.0
icon 2026-08-02

SFDA Approves Registration of "Foundayo" for Weight Management

The Saudi Food and Drug Authority (SFDA) has approved the registration of Foundayo (orforglipron) to help reduce excess body weight and maintain long...
More
مستحضر ٠اكسيد E
icon 2026-10-03

SFDA Approves Registration of "Jascayd" for the Treatment of Idiopathic Pulmonary Fibrosis

The Saudi Food and Drug Authority (SFDA) has approved the registration of Jascayd (nerandomilast) for the treatment of adult patients with idiopathic...
More